Carrasco C H, Freeny P C, Chuang V P, Wallace S
AJR Am J Roentgenol. 1983 Oct;141(4):703-6. doi: 10.2214/ajr.141.4.703.
The gallbladder often is included within the infusion territory during hepatic arterial chemotherapy, because the cystic artery usually originates from the right hepatic artery. Symptomatic cholecystitis associated with hepatic arterial infusion of mitomycin C and floxuridine or 5-fluorouracil was observed in four instances out of over 700 hepatic arterial infusions of chemotherapeutic agents performed over a 3-year period at two institutions. Arterial infusion chemotherapy is generally well tolerated by the gallbladder, and the true incidence of associated cholecystitis is unknown. Occasionally, angiographic features of cholecystitis are observed in asymptomatic patients after hepatic arterial infusion chemotherapy.
在肝动脉化疗期间,胆囊通常处于灌注区域内,因为胆囊动脉通常起源于肝右动脉。在两家机构为期3年进行的700多次肝动脉化疗药物灌注中,有4例观察到与丝裂霉素C、氟尿苷或5-氟尿嘧啶肝动脉灌注相关的症状性胆囊炎。胆囊对动脉灌注化疗通常耐受性良好,相关胆囊炎的真实发病率尚不清楚。偶尔,在肝动脉灌注化疗后,无症状患者中可观察到胆囊炎的血管造影特征。